Saw the resultant discussion on MXC and raised my eyebrows....there is some connection with MMJ, and it reminds me that originally Satipharm’s intention was to introduce the Gelpel into 10 other European countries last year (other than Germany and Poland). It could fit, but it’d be price sensitive and we’re yet to hear anything definitively from any Australian company.
Add to My Watchlist
What is My Watchlist?
